* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a rise in quarterly revenue when it reports results on
May 8.
* The Moorestown New Jersey-based company is expected to
report
a 25.1% increase in revenue to $83.982 million from $67.11
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. The company's guidance on
April 13 2023, for the period ended March 31, was for revenue
between $87.00 million and $88.50 million.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $6.75, above its last closing price
of $5.35.
The company's guidance on March 6 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD87 million and USD4 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.22 -0.06 -0.05 Beat 23.1
Sep. 30 2022 -0.19 -0.11 -0.26 Missed -132.1
Jun. 30 2022 -0.17 -0.12 -0.25 Missed -111.9
Mar. 31 2022 -0.16 -0.16 -0.22 Missed -40
Dec. -0.09 -0.08 -0.09 Missed -14.3
31 2021
Sep. 30 2021 0.02 0.03 -0.04 Missed -218.5
Jun. 30 2021 0.00 0.00 -0.01 Missed -200.3
Mar. 31 2021 -0.09 -0.09 -0.09 Met 2.4
This summary was machine generated May 6 at 02:05 GMT. All
figures in US dollars unless otherwise stated